News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
dispatches from bioprocess international
The products, unveiled at BioProcess International in Boston this week, will help industry with their upstream and downstream processing and include an anti-CHO host cell protein detection kit, the first single-use fermentor, and a new mammalian...
Encountering vanilla ice is a dreadful experience, as anyone who has found patches of frozen water and ingredients in ice cream can testify.
Eli Lilly’ manufacturing network will give it the edge in the glargine insulin market, the firm says having received tentative approval of its “Lantus look-alike” from the USFDA.
Personalized immunotherapy developer Argos Therapeutics has broken ground on a new 100,000 square-foot biomanufacturing facility in Durham, North Carolina.
Almost 300 workers will be made redundant at an R&D plant in Seattle, Washington as Amgen rolls out its restructure plan.